Brad Amos, MD, PhD, FAAD
Board-Certified Dermatologist
Google
5.0/5
Forefront Dermatology
Office staff was friendly. Doctors knowledgeable and processional. The new office space was really nice.
Google
5.0/5
Forefront Dermatology
Professional staff. Brad Amos is always a great doctor. Down to earth and very personable. Would highly recommend
Google
5.0/5
Forefront Dermatology
Doctor was extremely caring and nice. Answered any questions and explained things. Very pleased.
Google
5.0/5
Forefront Dermatology
Latterly saved my life. Very patient focused. I'm relieved I found dr.amos. God bless
Google
5.0/5
Forefront Dermatology
Quick professional service !
Google
5.0/5
Forefront Dermatology
Dr. Amos has worked with me over the past few years. He is knowledgeable and talented. He speaks to his patients in terms they understand and takes questions that help his patients better understand the aspects of their health problems with their skin and aspects thereto. I will continue to visit her and his team to discuss and improve my dermatology questions and health with his treatments and medications.
Google
5.0/5
Forefront Dermatology
Dr. Amos is always friendly and he is very thorough with his examination.
Google
5.0/5
Forefront Dermatology
Dr. Amos is five star dermatologist
Google
5.0/5
Forefront Dermatology
Thorough. Professional. Nothing negative to say. I’m a fan.
Google
5.0/5
Forefront Dermatology
Dr. Amos was so personable, and was thorough. He 'listens', and helps with any questions/comments. Highly recommend!
LOAD MORE REVIEWS
Education

Undergraduate Degree:

BS, University of Pittsburgh – Pittsburgh, PA

Doctorate Degree:

PhD, University of Texas – Houston, TX

Medical School:

MD, Baylor College of Medicine – Houston, TX

Dermatology Residency:

University of Pittsburgh – Pittsburgh, PA

Certificates
American Board of Dermatology
Publications
  • Barnes DW, Mousetis L, Amos B, and Silnutzer J Glass Bead Chromatography of Cell Attachment and Spreading Promoting Factors in Human Serum. Anal. Biochem. 127: 196-204, 1984.
  • Barnes DW, Reing JE, and Amos B. Heparin Binding Properties Of Human Serum Spreading Factor. J. Biol. Chem. 260: 9117-9122, 1985.
  • Lotan R, Lotan, D, and Amos B. Sialyltransferase in Two Melanoma Cell Lines That are Growth Inhibited by Retinoic Acid Results in Increased Sialylation of Different Cell Surface Glycoproteins. Exp. Cell Res. I 77: 284-294, 1988.
  • Amos, B. Clifford J. and Lotan R. Modulation of Melanoma Growth and Differentiation by Retinoids. Shroot 8. ed.
    “Pharmacology of Retino1ds m the Skin” S Karger, Basel· vol3: 29-36, 1989.
  • Sacks PG, Oke V, Amos B, Vasey T, and Lotan R. Modulation of Growth, Differentiation, and Glycoprotein Synthesis by P All Trans Retinoic Acid in a Multicellular Tumor Spheroid Model for Squamous Carcinoma of the Head and Neck.  Int. J Cancer 99: 926-933, 1989.
  • Amos B, Deutsch V, and Lotan R. Modulation by All Trans Retinoic Acid ofGlycosylation in Murine Melanoma Cells: Enhancement of Fucosyl and Galactosyltransferase Activities. CancerBiochem. B1ophys. 11: 31-43, 1990.
  • Amos B, Lotan D, and Lotan R. Increased Fucosylation of High Molecular Weight Glycoproteins Accompanies Retinoic Acid Differentiation ofF-9 Embryonal Carcinoma Cells. Int. J Cancer 46: 86-94, 1990.
  • Amos B and Lotan R. Modulation of Lysosomal Associated Membrane Glycoproteins (LAMPs 1 and 2) in Embryonal Carcinoma Cells Induced to Differentiate by Retinoic Acid. J. Biol. Chem. 265: 19192-19198, 1990.
  • Amos B and Lotan R. Retinoid Sensitive Cells and Cell Lines. In L. Packer (ed) Methods in Enzymology: Retinoids. Academic Press, Orlando. 190: 217-225
    Lotan R, Amos B, Watanabe H, and Raz A. Suppression ofMelanoma Cell Motility Factor Receptor Expression by Retinoic Acid. Cancer Res. 52: 4878-4884, 1992.
  • Heffernan M, Lotan R. Palcic M, Amos B, and Dennis JW. Branching of 13 l-6N-Acetylglucosamine-Transferase and Polylactosamine Expression in Mouse F-9 Teratocarcinorna Cells: Modulation During Retinoic Acid Induced Differentiation. J. Biol. Chem. 268: 1242-1251, 1993.
  • Sacks PG. Amos B, and Lotan R. Enhancement of Glycosylation of Cellular G\yconjugates in the Squamous Cell LineMDA886Ln by 13 All Trans Retinoic Acid. GlycoconjugateJ. 13: 791-796, 1996. Amos B, Deng JS, and Suarez S. Bullous Pemphlgoid in Infancy Case Report and Literature Review. Ped. Dermatol. 15: I 08-111, 1998.
  • Lu Y, Amos B, Cruise E, Lotan D, and Lotan R. A Parallel Association Between Differentiation and Induction of Galectin-1, And lnhibition of Galectin-3 by Retinoic Acid in Mouse Embryonal Carcinoma F9 Cells. Biol. Chem. 11: 1323-1331, 1998.
  • Chew J, Gin l, Rau KA, Amos B, and Bridenstine JB. Treatment of Upper Lip Wrinkles: A Comparison of950 musec Dwell Time Carbon Dioxide Laser with Unoccluded Baker’s Phenol Chemical Peel. Dermato/. Surg. 25: 262-266, 1999.
  • Gin I, Chew J, Rau KA, Amos DB, and Bridenstine JB. Treatment Of Upper Lip Wrinkles: A Comparison of950 musec Dwell Time Carbon Dioxide Laser to Manual Tumescent Dermabrasion. Dermatol. Surg. 25: 468-474, 1999.
  • Rau KA, Chew J, Gin I, Amos DB, and BridenstineJB. Treatment of Upper Lip Wrinkles: A Comparison of the Sharplan Silktouch Carbon Dioxide Laser with Ellman Radiosurgery.
    Am.Jo/CosmeticSurg. 17: 9-14,2000.

Age Restriction
For patients scheduling who are under 18 years of age (19 in Alabama and Nebraska) please make sure you have permission from your parent or legal guardian to schedule this appointment. Your parent or legal guardian must accompany you on your initial visit and on certain subsequent visits to provide appropriate informed consent.